VYGR — Voyager Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual balance sheet for Voyager Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	282	181	133	119	231
Net Total Accounts Receivable
Net Total Receivables	19	8.11	0.748	0.639	84.5
Prepaid Expenses
Total Other Current Assets
Total Current Assets	305	198	137	124	320
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	46.5	61.5	55.4	33.3	30
Long Term Investments
Other Long Term Assets
Total Assets	355	262	194	159	351
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	76	26.8	51	72.6	64.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	255	107	98.8	100	115
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	99.5	154	95.1	59	236
Total Liabilities & Shareholders' Equity	355	262	194	159	351
Total Common Shares Outstanding